In a new job - January 9, 2026
AstraZeneca appoints Head of Investor Relations
AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in Cambridge, UK.
In a new job - January 8, 2026
Q-linea announces changes in US commercial leadership
Q-linea has announces that Jim Kathrein will step down as VP US Commercial Operations.
In a new job - January 6, 2026
She is the new CEO of Alvotech
Alvotech has announced key senior leadership changes following a planned succession process.
In a new job - January 6, 2026
Nykode nominates new Chair of the Board
Nykode Therapeutics has announced the proposed election of Dr. Barbara Krebs-Pohl as the new Chair of the Board, succeeding Susanne Stuffers, who has served as interim Chair since April 2025.
In a new job - January 5, 2026
Gesynta Pharma forms Scientific Advisory Board
Gesynta Pharma has announced the formation of a Scientific Advisory Board (SAB) to provide strategic advice in the clinical development of vipoglanstat, a non-hormonal, non-opioid treatment for endometriosis that is currently in Phase 2 (the NOVA trial).
In a new job - January 2, 2026
Hedia appoints new CEO
Danish diabetes‑tech company Hedia is implementing a leadership change.
